{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:50:03Z","timestamp":1792522203320,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.farma.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:16:08Z","timestamp":1753456568000},"page":"T252-T260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Recommendations for the safe use of high-risk medications in pediatrics"],"prefix":"10.1016","volume":"49","author":[{"given":"Mar\u00eda Jos\u00e9","family":"Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Rodr\u00edguez Marrodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Prieto Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Villalobos Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Manrique Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Padilla Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Fern\u00e1ndez-Llamazares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Madrid Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2025.03.006_bb0005","series-title":"Policy brief","article-title":"Medication without harm","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.farma.2025.03.006_bb0010","series-title":"Plan de acci\u00f3n mundial para la seguridad del paciente 2021\u20132030: hacia la eliminaci\u00f3n de los dan\u00f1os evitables en la atenci\u00f3n de salud","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.farma.2025.03.006_bb0015","series-title":"Medication safety in high-risk situations","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.farma.2025.03.006_bb0020","doi-asserted-by":"crossref","unstructured":"Cohen MR, Smetzer JL, Tuohy NR, Kilo CM. High-alert medications: safeguarding against errors. En: Cohen MR, editor. Medication errors. 2nd ed. Washington (DC): American Pharmaceutical Association; 2007. p. 317\u2013411.","DOI":"10.21019\/9781582120928.ch14"},{"key":"10.1016\/j.farma.2025.03.006_bb0025","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.farma.2025.03.006_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/qshc.2006.019950","article-title":"Medication errors in pediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations","volume":"16","author":"Miller","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.farma.2025.03.006_bb0035","series-title":"Estrategia de seguridad del paciente del sistema nacional de salud. Periodo 2015\u20132020","author":"Ministerio de Sanidad, Servicios Sociales e Igualdad","year":"2015"},{"key":"10.1016\/j.farma.2025.03.006_bb0040","series-title":"Recomendaciones para el uso seguro de los medicamentos de alto riesgo","author":"Ministerio de Sanidad. Instituto para el Uso Seguro de los Medicamentos","year":"2023"},{"key":"10.1016\/j.farma.2025.03.006_bb0045","series-title":"Recomendaciones para el uso seguro de los medicamentos de alto riesgo en Pediatr\u00eda","author":"Ministerio de Sanidad, Instituto para el Uso Seguro de los Medicamentos, Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda y Sociedad Espa\u00f1ola de Farmacia Hospitalaria","year":"2024"},{"key":"10.1016\/j.farma.2025.03.006_bb0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/14740338.2013.825247","article-title":"High-alert medications for pediatric patients: an international modified Delphi study","volume":"12","author":"Maaskant","year":"2013","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.farma.2025.03.006_bb0055","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/apa.15273","article-title":"Cross-sectional study identifying high-alert substances in medication error reporting among Swedish pediatric inpatients","volume":"109","author":"Nydert","year":"2020","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.farma.2025.03.006_bb0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PCC.0b013e3181936ff8","article-title":"High-alert medications in the pediatric intensive care unit","volume":"10","author":"Franke","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.farma.2025.03.006_bb0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anpedi.2013.04.026","article-title":"Lista modelo de medicamentos de alto riesgo","volume":"79","author":"Cotrina Luque","year":"2013","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.farma.2025.03.006_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jep.12302","article-title":"High-alert medications in a French paediatric university hospital","volume":"21","author":"Bataille","year":"2015","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.farma.2025.03.006_bb0075","first-page":"207","article-title":"High-alert medications for hospitalized pediatric patient - a two-step survey among pediatric clinical expert pharmacists in Germany","volume":"77","author":"Schilling","year":"2022","journal-title":"Pharmazie"},{"key":"10.1016\/j.farma.2025.03.006_bb0080","first-page":"1","volume":"18","year":"2013","journal-title":"ISMP Medication Safety Alert!"},{"key":"10.1016\/j.farma.2025.03.006_bb0085","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2146\/ajhp170811","article-title":"ASHP guidelines on preventing medication errors in hospitals","volume":"75","author":"Billstein-Leber","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.farma.2025.03.006_bb0090","unstructured":"Health Information and Quality Authority. Guide to HIQA's medication safety monitoring programme against the National Standards for Safer, Better Healthcare in Acute Healthcare Services in 2019. [accessed 20 Jan 2025]. Available from: https:\/\/www.hiqa.ie\/sites\/default\/files\/2019-01\/Medication Safety Monitoring Programme Guide 2019.pdf."},{"key":"10.1016\/j.farma.2025.03.006_bb0095","author":"Government of Western Australia. Department of Health. Health high risk medication policy, 2020"},{"key":"10.1016\/j.farma.2025.03.006_bb0100","series-title":"Joint Commission International Accreditation Standards for Hospitals","author":"Joint Commission International","year":"2023"},{"key":"10.1016\/j.farma.2025.03.006_bb0105","author":"ISMP Canada. Canadian high-alert medication list. User guide 2024 edition"},{"key":"10.1016\/j.farma.2025.03.006_bb0110","author":"NSW Government. Clinical Excellence Commission. High-risk medicines management, 2024"},{"key":"10.1016\/j.farma.2025.03.006_bb0115","author":"U.S. Department of Health, Human Services, Office of Disease Prevention, Health Promotion. National action plan for adverse drug event prevention. Washington (DC), 2014"},{"key":"10.1016\/j.farma.2025.03.006_bb0120","author":"Ministry of Health Singapore. The National guidelines on high alert medications, 2021"},{"key":"10.1016\/j.farma.2025.03.006_bb0125","year":"2024","journal-title":"ISMP"},{"key":"10.1016\/j.farma.2025.03.006_bb0130","first-page":"1","volume":"4","author":"ISMP-Canada. Designing effective recommendations. Ontario critical incident learning","year":"2013"},{"key":"10.1016\/j.farma.2025.03.006_bb0135","first-page":"1","article-title":"Education is \u201cpredictably disappointed\u201d and should never be relied upon alone to improve safety","volume":"25","author":"Institute for Safe Medication Practices","year":"2020","journal-title":"ISMP Med Saf Alert"},{"issue":"4 Pt 1","key":"10.1016\/j.farma.2025.03.006_bb0140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.111.4.722","article-title":"Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients","volume":"111","author":"Fortescue","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.farma.2025.03.006_bb0145","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1542\/peds.2007-0220","article-title":"Effect of computer order entry on prevention of serious medication errors in hospitalized children","volume":"121","author":"Walsh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.farma.2025.03.006_bb0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/archdischild-2011-301239","article-title":"Impact of clinical pharmacist interventions in reducing pediatric prescribing errors","volume":"97","author":"Fern\u00e1ndez-Llamazares","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.farma.2025.03.006_bb0155","first-page":"96","article-title":"Medication errors affecting pediatric patients: Unique challenges for this special population","volume":"12","author":"Pennsylvania Patient Safety Authority","year":"2015","journal-title":"Pa Patient Saf Advis"},{"key":"10.1016\/j.farma.2025.03.006_bb0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.medin.2016.01.011","article-title":"Safe intravenous administration in pediatrics: a 5-year pediatric intensive care unit experience with smart pumps","volume":"40","author":"Manrique-Rodr\u00edguez","year":"2016","journal-title":"Med Intensiva"},{"key":"10.1016\/j.farma.2025.03.006_bb0165","year":"2017","journal-title":"ISMP"},{"key":"10.1016\/j.farma.2025.03.006_bb0170","series-title":"Cuestionario de autoevaluaci\u00f3n de la seguridad del sistema de utilizaci\u00f3n de los medicamentos en los hospitales. Versi\u00f3n Espa\u00f1ola II (2018)","author":"Ministerio de Sanidad, Servicios Sociales e Igualdad","year":"2018"},{"key":"10.1016\/j.farma.2025.03.006_bb0175","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jphp.12992","article-title":"A national scoping survey of standard infusions in pediatric and neonatal intensive care units in the United Kingdom","volume":"70","author":"Oskarsdottir","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.farma.2025.03.006_bb0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0040-1709508","article-title":"The impact of technology on prescribing errors in pediatric intensive care: a before and after study","volume":"11","author":"Howlett","year":"2020","journal-title":"Appl Clin Inform"},{"key":"10.1016\/j.farma.2025.03.006_bb0185","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/17425247.2023.2273838","article-title":"Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors a comprehensive review","volume":"20","author":"Chachlioutaki","year":"2023","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.farma.2025.03.006_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11096-023-01652-3","article-title":"Implementation of a national system for best practice delivery of pediatric infusions","volume":"46","author":"Howlett","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.farma.2025.03.006_bb0195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ejhpharm-2022-003316","article-title":"Standardization of intravenous infusion therapy for pediatrics: big challenges for the little patients","volume":"31","author":"Taladriz-Sender","year":"2024","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.farma.2025.03.006_bb0200","series-title":"Cinco momentos clave para la utilizaci\u00f3n segura de los medicamentos. Gu\u00eda para los profesionales sanitarios","author":"Ministerio de Sanidad","year":"2022"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:49:05Z","timestamp":1770680945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1130634325000248"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.006","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Recommendations for the safe use of high-risk medications in pediatrics","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a S.L.U. on behalf of Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda and Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H).","name":"copyright","label":"Copyright"}]}}